Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transforming growth factor-β in tumour development. | Front Mol Biosci | 2022 | 36267157 | PubTator, text mining | PubMed |
| Case report: Diagnosis of hereditary hemorrhagic telangiectasia (Osler Weber Rendu Syndrome) in a 23-year-old male presented with anemia and thrombocytopenia and its response to bevacizumab. | Front Med (Lausanne) | 2022 | 36262274 | PubTator, text mining | PubMed |
| The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis. | PLoS Negl Trop Dis | 2022 | 36260617 | PubTator, text mining | PubMed |
| An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms. | Front Med (Lausanne) | 2022 | 36250069 | PubTator, text mining | PubMed |
| Differential modulation of cancer-related genes by mitochondrial DNA haplogroups and the STING DNA sensing system. | FASEB Bioadv | 2022 | 36238361 | PubTator, text mining | PubMed |
| Novel Insights into the Effects of Genetic Variants on Serum Urate Response to an Acute Fructose Challenge: A Pilot Study. | Nutrients | 2022 | 36235682 | PubTator, text mining | PubMed |
| Lipid Metabolism in Cartilage Development, Degeneration, and Regeneration. | Nutrients | 2022 | 36235637 | PubTator, text mining | PubMed |
| Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review. | J Clin Med | 2022 | 36233492 | PubTator, text mining | PubMed |
| Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A. | Int J Mol Sci | 2022 | 36232920 | PubTator, text mining | PubMed |
| On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping. | Int J Mol Sci | 2022 | 36232732 | PubTator, text mining | PubMed |
| Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End? | Cells | 2022 | 36231142 | PubTator, text mining | PubMed |
| Brain Endothelial Cells in Contrary to the Aortic Do Not Transport but Degrade Low-Density Lipoproteins via Both LDLR and ALK1. | Cells | 2022 | 36231005 | PubTator, text mining | PubMed |
| Angiomatoid Fibrous Histiocytoma: A Tumor With Uncertain Behavior and Various Clinicopathological Presentations. | Cureus | 2022 | 36225497 | PubTator, text mining | PubMed |
| Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TGFβ2/ALK1 axis. | Exp Mol Med | 2022 | 36224344 | PubTator, text mining | PubMed |
| Bioinformatic analysis of the LCN2-SLC22A17-MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment. | Front Cell Dev Biol | 2022 | 36211450 | PubTator, text mining | PubMed |
| Cellular loci involved in the development of brain arteriovenous malformations. | Front Hum Neurosci | 2022 | 36211120 | PubTator, text mining | PubMed |
| Primary Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma (ALCL) Presenting as Perforation Peritonitis: A Case Report and Management Principles. | Cureus | 2022 | 36211108 | PubTator, text mining | PubMed |
| Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling. | Front Pharmacol | 2022 | 36210850 | PubTator, text mining | PubMed |
| Associations of Reported Genetic Risk Loci with Sporadic Brain Arteriovenous Malformations: Meta-analysis. | J Mol Neurosci | 2022 | 36209311 | PubTator, text mining | PubMed |
| Extracranial arteriovenous malformations demonstrate dysregulated TGF-β/BMP signaling and increased circulating TGF-β1. | Sci Rep | 2022 | 36198763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=32